Savara Pharmaceuticals, an Austin, Texas-based developer of inhalation drug delivery solutions, has closed its Series A round in excess of its $1.4 million target. No investor information was disclosed.
2 min read · 16 December 2009
SmartDrive Systems Inc., a San Diego-based provider of driver risk management systems and services, has raised $25 million in fifth-round funding co-led by return backers New Enterprise Associates and Oak Investment Partners. SmartDrive previously raised over $50 million from NEA, Oak, Revolution Ventures, the Founders Fund and Western Technology Investments.
2 min read · 16 December 2009
QD Vision, a Watertown, Mass.-based developer of nanotech-based products for solid state lighting and displays, has raised $10 million in fourth-round funding. Return backers include North Bridge Venture Partners, Highland Capital Partners and In-Q-Tel.
4 min read · 16 December 2009
1 min read · 16 December 2009
Thomson Reuters (NYSE: TRI) has completed its acquisition of Sabrix Inc., a San Ramon, Calif.-based provider of transaction tax management software. No financial terms were disclosed. Sabrix has raised around $40 million in VC funding since 2000, from firms like Trinity Ventures, Mohr Davidow Ventures, GKM Ventures and VSP Capital.
2 min read · 16 December 2009
Silence Therapeutics PLC (AIM: SLN) has agreed to merge with Intradigm Corp., a Palo Alto, Calif.-based developer of RNAi therapeutics. Intradigm previously raised around $42 million in VC funding from firms like Alta Partners, Frazier Healthcare, Lilly Ventures, Roche Finance and Astellas Venture. Those firms now hold a 36.6% stake in the combined company, and agreed to invest £5 million in new capital.
7 min read · 16 December 2009
IBM has agreed to acquire Lombardi Software, an Austin, Texas-based developer of business process management software. No financial terms were disclosed. Lombardi has raised around $78 million in VC funding, from firms like Austin Ventures, InterWest Partners and Palomar Ventures.
4 min read · 16 December 2009
Afferent Pharmaceuticals, a Palo Alto, Calif.-based developer of drugs for chronic pain, has raised $23 million in Series A funding. Third Rock Ventures and Pappas Ventures co-led the round, and were joined by Domain Associates and New Leaf Venture Partners. In related news, Afferent has licensed a chronic pain program from Roche.
7 min read · 16 December 2009
2 min read · 16 December 2009
Kobo Inc., a developer of mobile eBook applications, has raised $16 million from Borders Group Inc. (NYSE: BGP), as part of its spinout from Toronto-based Indigo Books & Music. The investment is part of a commercial partnership whereby Borders will brand and stock Kobo's eBook stores.
3 min read · 16 December 2009
